{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T00:09:04Z","timestamp":1783901344031,"version":"3.55.0"},"reference-count":19,"publisher":"Walter de Gruyter GmbH","issue":"4","license":[{"start":{"date-parts":[[2023,7,13]],"date-time":"2023-07-13T00:00:00Z","timestamp":1689206400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,12,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>t(14;18)(q32;q21) translocation is an important genetic feature of follicular lymphoma resulting in antiapoptotic B-cell lymphoma 2 (BCL2) protein overexpression. On chromosome 18 breakpoint-site variation is high but does not affect BCL2. Breakpoint most commonly occurs at major breakpoint region (MBR) but may happen at minor cluster region (mcr) and between MBR and mcr at 3\u2032MBR and 5\u2032mcr. The aim of this study was to analyze the correlation of t(14;18)(q32;q21) breakpoint site with clinical characteristics in follicular lymphoma.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Patients and methods<\/jats:title>\n                    <jats:p>We included patients diagnosed with follicular lymphoma who received at least 1 cycle of systemic treatment and had the t(14;18)(q32;q21) translocation detected by polymerase chain reaction (PCR) at MBR, mcr or 3\u2032MBR prior to first treatment. Among patients with different breakpoints, sex, age, disease grade, stage, B-symptoms, follicular lymphoma international prognostic index (FLIPI), presence of bulky disease, progression free survival and overall survival were compared.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Of 84 patients, 63 had breakpoint at MBR, 17 at mcr and 4 at 3\u2032MBR. At diagnosis, the MBR group had a significantly lower disease stage than the mcr group. Although not significant, in the MBR group we found a higher progression-free survival (PFS) and overall survival (OS), lower grade, age, FLIPI, and less B-symptoms.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Compared to patients with mcr breakpoint, those with MBR breakpoint seem to be characterised by more favourable clinical characteristics. However, a larger study would be required to support our observation.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.2478\/raon-2023-0030","type":"journal-article","created":{"date-parts":[[2023,7,13]],"date-time":"2023-07-13T03:42:27Z","timestamp":1689219747000},"page":"487-492","source":"Crossref","is-referenced-by-count":2,"title":["Correlation of t(14;18) translocation breakpoint site with clinical characteristics in follicular lymphoma"],"prefix":"10.2478","volume":"57","author":[{"given":"Matej","family":"Panjan","sequence":"first","affiliation":[{"name":"Division of Medical Oncology , Institute of Oncology Ljubljana , Ljubljana , Slovenia"},{"name":"Medical Faculty Ljubljana , University of Ljubljana , Ljubljana , Slovenia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucka","family":"Boltezar","sequence":"additional","affiliation":[{"name":"Division of Medical Oncology , Institute of Oncology Ljubljana , Ljubljana , Slovenia"},{"name":"Medical Faculty Ljubljana , University of Ljubljana , Ljubljana , Slovenia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Srdjan","family":"Novakovic","sequence":"additional","affiliation":[{"name":"Medical Faculty Ljubljana , University of Ljubljana , Ljubljana , Slovenia"},{"name":"Department of Molecular Diagnostics , Institute of Oncology Ljubljana , Ljubljana , Slovenia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ira","family":"Kokovic","sequence":"additional","affiliation":[{"name":"Department of Molecular Diagnostics , Institute of Oncology Ljubljana , Ljubljana , Slovenia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Jezersek Novakovic","sequence":"additional","affiliation":[{"name":"Division of Medical Oncology , Institute of Oncology Ljubljana , Ljubljana , Slovenia"},{"name":"Medical Faculty Ljubljana , University of Ljubljana , Ljubljana , Slovenia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"374","published-online":{"date-parts":[[2023,7,13]]},"reference":[{"key":"2026071211421888216_j_raon-2023-0030_ref_001","doi-asserted-by":"crossref","unstructured":"Dada R. Diagnosis and management of follicular lymphoma: a comprehensive review. Eur J Hematol 2019; 103: 152\u201363. doi: 10.1111\/ejh.13271","DOI":"10.1111\/ejh.13271"},{"key":"2026071211421888216_j_raon-2023-0030_ref_002","doi-asserted-by":"crossref","unstructured":"Aster JC, Longtine JA. Detection of BCL2 rearrangements in follicular lymphoma. Am J Pathol 2002; 160: 759\u201363. doi: 10.1016\/S0002-9440(10)64897-3","DOI":"10.1016\/S0002-9440(10)64897-3"},{"key":"2026071211421888216_j_raon-2023-0030_ref_003","doi-asserted-by":"crossref","unstructured":"Goodlad JR, Batstone PJ, Hamilton DA, Kernohan NM, Levison DA, White JM. BCL2 gene abnormalities define distinct clinical subsets of follicular lymphoma. Histopathology 2006; 49: 229\u201341. doi: 10.1111\/j.1365-2559.2006.02501.x","DOI":"10.1111\/j.1365-2559.2006.02501.x"},{"key":"2026071211421888216_j_raon-2023-0030_ref_004","doi-asserted-by":"crossref","unstructured":"Johnson A, Brumn A, Dictor M, Rambech E, Akerman M, Anderson H. Incidence and prognostic significance of t(14;18) translocation in follicle center cell lymphoma of low and high grade. A report from southern Sweden. Ann Oncol 1995; 6: 789\u201394. doi: 10.1093\/oxfordjournals.annonc.a059317","DOI":"10.1093\/oxfordjournals.annonc.a059317"},{"key":"2026071211421888216_j_raon-2023-0030_ref_005","doi-asserted-by":"crossref","unstructured":"Schuetz JM, Johnson NA, Morin RD, Scott DW, Tan K, Ben-Nierah S, et al. BCL2 mutations in diffuse large B-cell lymphoma. Leukemia 2012; 26: 1383\u201390. doi: 10.1038\/leu.2011.378","DOI":"10.1038\/leu.2011.378"},{"key":"2026071211421888216_j_raon-2023-0030_ref_006","doi-asserted-by":"crossref","unstructured":"Buckstein R, Pennell N, Berinstein NL. What is remission in follicular lymphoma and what is its relevance? Best Pract Res Clin Haematol 2005; 18: 27\u201356. doi: 10.1016\/j.beha.2004.08.019","DOI":"10.1016\/j.beha.2004.08.019"},{"key":"2026071211421888216_j_raon-2023-0030_ref_007","doi-asserted-by":"crossref","unstructured":"Tsujimoto Y, Finger LR, Yunis J, Nowell PC, Croce CM. Cloning of the chromosome breakpoint of neoplastic B cells with the t(14;18) chromosome translocation. Science 1984; 226: 1097\u20139. doi: 10.1126\/science.6093263","DOI":"10.1126\/science.6093263"},{"key":"2026071211421888216_j_raon-2023-0030_ref_008","doi-asserted-by":"crossref","unstructured":"Marie Hardwick J, Soane L. Multiple functions of BCL-2 family proteins. Cold Spring Harb Perspect Biol 2013; 5: a008722. doi: 10.1101\/cshperspect.a008722","DOI":"10.1101\/cshperspect.a008722"},{"key":"2026071211421888216_j_raon-2023-0030_ref_009","doi-asserted-by":"crossref","unstructured":"Vaux DL, Cory S, Adams JM. Bcl-2 gene promotes haemopoietic cell survival and cooperates with c-myc to immortalize pre-B cells. Nature 1988; 335: 440\u20132. doi: 10.1038\/335440a0","DOI":"10.1038\/335440a0"},{"key":"2026071211421888216_j_raon-2023-0030_ref_010","doi-asserted-by":"crossref","unstructured":"Horsman DE, Connors JM, Pantzar T, Gascoyne RD. Analysis of secondary chromosomal alterations in 165 cases of follicular lymphoma with t(14;18). Genes Chromosomes Cancer 2001, 30: 375\u201382. doi: 10.1002\/gcc.1103","DOI":"10.1002\/gcc.1103"},{"key":"2026071211421888216_j_raon-2023-0030_ref_011","doi-asserted-by":"crossref","unstructured":"Yunis JJ, Oken MM, Kaplan ME, Ensrud KM, Howe RR, Theologides A. Distinctive chromosomal abnormalities in histologic subtypes of non-Hodgkin's lymphoma. N Engl J Med 1982; 307: 1231\u20136. doi: 10.1056\/NEJM198211113072002","DOI":"10.1056\/NEJM198211113072002"},{"key":"2026071211421888216_j_raon-2023-0030_ref_012","doi-asserted-by":"crossref","unstructured":"Vaandrager JW, Schuuring E, Raap T, Philippo K, Kleiverda K, Kluin P. Interphase FISH detection of BCL2 rearrangement in follicular lymphoma using breakpoint-flanking probes. Genes Chromosomes Cancer 2000; 27: 85\u201394. doi: 10.1002\/(SICI)1098-2264(200001)27:1<85::AID-GCC11>3.0.CO;2-9","DOI":"10.1002\/(SICI)1098-2264(200001)27:1<85::AID-GCC11>3.0.CO;2-9"},{"key":"2026071211421888216_j_raon-2023-0030_ref_013","doi-asserted-by":"crossref","unstructured":"Horsman DE, Gascoyne RD, Coupland RW, Coldman AJ, Adomat SA. Comparison of cytogenetic analysis, southern analysis, and polymerase chain reaction for the detection of t(14; 18) in follicular lymphoma. Am J Clin Pathol 1995; 103: 472\u20138. doi: 10.1093\/ajcp\/103.4.472","DOI":"10.1093\/ajcp\/103.4.472"},{"key":"2026071211421888216_j_raon-2023-0030_ref_014","doi-asserted-by":"crossref","unstructured":"Barrans SL, Evans PAS, O\u2019Connor SJM, Owen RG, Morgan GJ, Jack AS. The detection of t(14;18) in archival lymph nodes: development of a fluorescence in situ hybridization (FISH)-based method and evaluation by comparison with polymerase chain reaction. J Mol Diagn 2003; 5: 168. doi: 10.1016\/S1525-1578(10)60469-2","DOI":"10.1016\/S1525-1578(10)60469-2"},{"key":"2026071211421888216_j_raon-2023-0030_ref_015","doi-asserted-by":"crossref","unstructured":"Gu K, Chan WC, Hawley RC. Practical detection of t(14;18)(IgH\/BCL2) in follicular lymphoma. Arch Pathol Lab Med 2008; 132: 1355\u201361. doi: 10.5858\/2008-132-1355-PDOBIF","DOI":"10.5858\/2008-132-1355-PDOBIF"},{"key":"2026071211421888216_j_raon-2023-0030_ref_016","doi-asserted-by":"crossref","unstructured":"van Dongen JJM, Langerak AW, Br\u00fcggemann M, Evans P a. S, Hummel M, Lavender FL, et al. Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations: report of the BIOMED-2 Concerted Action BMH4-CT98-3936. Leukemia 2003; 17: 2257\u2013317. doi: 10.1038\/sj.leu.2403202","DOI":"10.1038\/sj.leu.2403202"},{"key":"2026071211421888216_j_raon-2023-0030_ref_017","doi-asserted-by":"crossref","unstructured":"Galteland E, Sivertsen EA, Svendsrud DH, Smedshammer L, Kresse SH, Meza-Zepeda LA, et al. Translocation t(14;18) and gain of chromosome 18\/BCL2: effects on BCL2 expression and apoptosis in B-cell non-Hodgkin's lymphomas. Leukemia 2005; 19: 2313\u201323. doi: 10.1038\/sj.leu.2403954","DOI":"10.1038\/sj.leu.2403954"},{"key":"2026071211421888216_j_raon-2023-0030_ref_018","doi-asserted-by":"crossref","unstructured":"Weinberg OK, Ai ZW, Mariappan MR, Shum C, Levy R, Arber DA. \u201cMinor\u201d BCL2 breakpoints in follicular lymphoma: frequency and correlation with grade and disease presentation in 236 cases. J Mol Diagn 2007; 9: 530. doi: 10.2353\/jmoldx.2007.070038","DOI":"10.2353\/jmoldx.2007.070038"},{"key":"2026071211421888216_j_raon-2023-0030_ref_019","doi-asserted-by":"crossref","unstructured":"L\u00f3pez-Guillermo A, Cabanillas F, McDonnell TI, McLaughlin P, Smith T, Pugh W, et al. Correlation of Bcl-2 rearrangement with clinical characteristics and outcome in indolent follicular lymphoma. Blood 1999; 93: 3081\u20137. doi: 10.1182\/blood.V93.12.4365","DOI":"10.1182\/blood.V93.9.3081.409a43_3081_3087"}],"container-title":["Radiology and Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/reference-global.com\/pdf\/10.2478\/raon-2023-0030","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,12]],"date-time":"2026-07-12T23:35:51Z","timestamp":1783899351000},"score":1,"resource":{"primary":{"URL":"https:\/\/reference-global.com\/article\/10.2478\/raon-2023-0030"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,13]]},"references-count":19,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2023,7,13]]},"published-print":{"date-parts":[[2023,12,1]]}},"alternative-id":["10.2478\/raon-2023-0030"],"URL":"https:\/\/doi.org\/10.2478\/raon-2023-0030","relation":{},"ISSN":["1581-3207"],"issn-type":[{"value":"1581-3207","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,7,13]]}}}